Loading
Latest filing published 08 Oct 2026 for 바이오플러스. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 정현규 in 바이오플러스, where the filings describe the role as chief executive. Between 30 September 2021 and 8 October 2026, the trades on record add up to 38 filings.
Market trades split into 9 purchases and 3 sales. The totals do not cover 12 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and no sales on the market.
None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 8 October 2026, reports a transaction in 바이오플러스. The clock since the last published purchase (2 April 2026) now reads 199 days. Filings reach the DART (FSS) feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations